新华社北京11月5日电（记者彭韵佳）据国家医保局最新消息，2025年国家基本医保药品目录谈判竞价 和商保创新药目录价格协商工作在10月30日至11月3日开展，共有120家内外资企业现场参与，参与基本 医保药品目录谈判竞价的目录外药品127个，参与商保创新药目录价格协商的药品24个。 【纠错】 【责任编辑:谷玥】 与往年不同，今年目录调整中增设了商保创新药目录，与基本医保目录相关工作同步进行。国家医保局 介绍，后续相关技术、行政和法律程序完成后，新版基本医保药品目录及首版商保创新药目录拟于12月 第一个周末在广州线上线下同步发布，并将于2026年1月1日起正式实施。 ...

Core Points - The new basic medical insurance drug catalog and the first version of the commercial insurance innovative drug catalog are set to be released in Guangzhou on the first weekend of December, with implementation starting on January 1, 2024 [1] - The recent negotiations involved 120 domestic and foreign enterprises, with 127 drugs outside the basic medical insurance catalog participating in the negotiations, and 24 drugs involved in price negotiations for the commercial insurance innovative drug catalog [3] - The commercial insurance innovative drug catalog was organized by the National Medical Insurance Administration, allowing companies to apply for inclusion in either the basic medical insurance catalog or the commercial insurance innovative drug catalog, or both [5] Industry Insights - The addition of the commercial insurance innovative drug catalog aims to better meet the diverse medication needs of the population, with 1.326 billion people covered by basic medical insurance in 2024, maintaining a coverage rate of 95% [6] - Total expenditure for the basic medical insurance fund is projected to reach 2.97 trillion yuan in 2024, providing solid support for healthcare access [6] - The commercial health insurance market is experiencing rapid growth, with premium income reaching 977.3 billion yuan in 2024, an increase of 8.2% year-on-year, although there remains significant room for improvement in coverage levels compared to basic medical insurance [6] - Challenges exist in synchronizing medical insurance and commercial insurance settlements across provinces, but initiatives like the "commercial insurance + medical insurance" one-stop settlement payment platforms have been launched in various regions [6]

后续相关技术、行政和法律程序完成后，新版基本医保药品目录及首版商保创新药目录拟于12月第一个 周末在广州线上线下（300959）同步发布，明年1月1日起正式实施。 新京报讯据国家医保局官微消息，10月30日至11月3日，国家医保局组织开展2025年国家基本医保药品 目录谈判竞价和商保创新药目录价格协商工作，120家内外资企业现场参与，其中参与基本医保药品目 录谈判竞价的目录外药品127个，参与商保创新药目录价格协商的药品24个。 ...